Filing Details

Accession Number:
0001576280-25-000094
Form Type:
4
Zero Holdings:
No
Publication Time:
2025-03-18 17:27:56
Reporting Period:
2025-03-15
Filing Date:
2025-03-18
Accepted Time:
2025-03-18 17:27:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1576280 Guardant Health Inc. GH Services-Medical Laboratories (8071) 454139254
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1927831 Kumud Kalia 3100 Hanover Street
Palo Alto CA 94304
Chief Information Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2025-03-15 637 $0.00 23,448 No 4 M Direct
Common Stock Disposition 2025-03-15 228 $42.89 23,220 No 4 F Direct
Common Stock Disposition 2025-03-17 3,500 $43.16 19,720 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2025-03-15 637 $0.00 637 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
3,187 No 4 M Direct
Footnotes
  1. These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
  2. This represents a restricted stock unit award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 15, 2024 and the remaining 67% of the shares vest in equal quarterly installments over the remaining two-year period thereafter.
  3. Not applicable for Restricted Stock Units.